08 Apr2024Vivet Therapeutics Doses First Patient In Cohort 2 In Phase 1/2 GATEWAY Clinical Trial For Treatment Of Wilson DiseaseAuthor By Healthufit Posted on April 8, 2024April 8, 2024Vivet Therapeutics Doses First Patient In Cohort 2 In Phase 1/2 GATEWAY Cli...